Metabolomic mapping of atypical antipsychotic effects in schizophrenia. (Q34620002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Metabolomic mapping of atypical antipsychotic effects in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Rebecca Baillie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

McEvoy J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lee D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yao JK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Doraiswamy PM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Krishnan KR

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

17 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

934-945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17440431%20AND%20SRC:MED&resulttype=core&format=json

Biological studies in schizophrenia

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

Psychopharmacologic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

1 reference

7 January 2021

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Metabolomic analysis and signatures in motor neuron disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Metabolic investigation in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or alpha-linolenic acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Triglyceride levels are ethnic-specifically associated with an index of stearoyl-CoA desaturase activity and n-3 PUFA levels in Asians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Metabolic profiling of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Erythrocyte membrane phospholipids in psychotic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Schizophrenia as a membrane lipid disorder which is expressed throughout the body

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Essential fatty acids in plasma phospholipids in schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021

Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002000

7 January 2021